Kappa agonists, especially for the treatment and/or prophylaxis of irritable bowel syndrome

Details for Australian Patent Application No. 2004256892 (hide)

Owner Merck Patent GmbH

Inventors Stahle, Wolfgang; Seyfried, Christoph; Gottschlich, Rudolf; Harting, Jurgen

Agent Davies Collison Cave

Pub. Number AU-A-2004256892

PCT Pub. Number WO2005/007626

Priority 103 31 723.6 11.07.03 DE

Filing date 18 June 2004

Wipo publication date 27 January 2005

International Classifications

C07D 207/12 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

Event Publications

2 March 2006 PCT application entered the National Phase

  PCT publication WO2005/007626 Priority application(s): WO2005/007626

24 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004256945-Substituted tetrahydro1H-pyrazolo(3,4-c)pyridines, compositions containing same and use

2004256886-Novel fusidic acid derivatives